Tag:
NVC-422
Latest Headlines
Latest Headlines
NovaBay's impetigo drug aces Phase II trial
NovaBay Pharmaceuticals' lead drug candidate NVC-422 was shown to be safe and effective in a mid-stage trial. The drug was tested at three doses against the contagious skin infection impetigo,
